Yes, there are.
The question is if there are enough and if they are targeting the right issues in time. Of course, there are discussions and preparations. When it comes to the pharmaceutical benefit scheme, I would not say that we do anything differently than we would have done otherwise. Other agencies in Sweden are focused on providing more guidelines, and they're working with issues when it comes to the elderly who use a lot of drugs. There have been governmental reforms targeted at reducing the number of pharmaceuticals that the elderly use, especially pharmaceuticals without good directions for people's health. That work has been going on for some years. We see that it will need to be enhanced further in the coming years.